Quigley Jill M. 4
4 · Terns Pharmaceuticals, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Quigley Jill M.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-04$9.24/sh+24,520$226,565→ 24,520 total - Sale
Common Stock
2025-11-04$18.00/sh−24,520$441,360→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-04−24,520→ 3,955 totalExercise: $9.24Exp: 2030-12-29→ Common Stock (24,520 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- [F2]1/3rd of the shares subject to the option vested on the first anniversary measured from December 29, 2020 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vested monthly thereafter, such that 100% of the shares subject to the option were fully vested and exercisable on the third anniversary of the Vesting Commencement Date.